Todays Report: Today, Analysts give average Rating of “Buy” to Zimmer Biomet Holdings Inc. (ZBH)

Today, Analysts give average Rating of “Buy” to Zimmer Biomet Holdings Inc. (ZBH)

Shares of Zimmer Biomet Holdings Inc. (NYSE:ZBH) have earned an average recommendation of “Buy” from the twenty-six research firms that are presently covering the firm. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, twenty have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $131.74.

Several equities research analysts have recently weighed in on ZBH shares. Jefferies Group increased their target price on shares of Zimmer Biomet Holdings from $135.00 to $150.00 and gave the stock a “buy” rating in a research note on Friday, July 29th. Needham & Company LLC raised their price objective on shares of Zimmer Biomet Holdings from $143.00 to $150.00 and gave the company a “buy” rating in a research report on Friday, July 29th. SunTrust Banks Inc. initiated coverage on shares of Zimmer Biomet Holdings in a research report on Thursday, August 11th. They issued a “buy” rating and a $155.00 price objective for the company. BMO Capital Markets restated a “buy” rating and issued a $146.00 price objective on shares of Zimmer Biomet Holdings in a research report on Friday, July 29th. Finally, Canaccord Genuity restated a “buy” rating and issued a $130.00 price objective (down previously from $150.00) on shares of Zimmer Biomet Holdings in a research report on Monday, October 31st.

Shares of Zimmer Biomet Holdings (NYSE:ZBH) traded up 1.68% on Friday, hitting $102.70. The stock had a trading volume of 347,249 shares. Zimmer Biomet Holdings has a one year low of $88.27 and a one year high of $133.21. The company’s 50 day moving average is $114.43 and its 200 day moving average is $121.78. The stock has a market cap of $20.57 billion, a PE ratio of 57.50 and a beta of 1.28.

Zimmer Biomet Holdings (NYSE:ZBH) last announced its earnings results on Monday, October 31st. The company reported $1.79 earnings per share for the quarter, hitting the consensus estimate of $1.79. Zimmer Biomet Holdings had a net margin of 3.46% and a return on equity of 16.48%. The business earned $1.83 billion during the quarter, compared to the consensus estimate of $950.20 million. During the same quarter in the prior year, the firm earned $1.64 earnings per share. The business’s quarterly revenue was up 4.0% compared to the same quarter last year. Equities research analysts predict that Zimmer Biomet Holdings will post $7.92 EPS for the current fiscal year.

In related news, insider Daniel E. Williamson sold 2,716 shares of the firm’s stock in a transaction that occurred on Thursday, September 8th. The shares were sold at an average price of $129.96, for a total transaction of $352,971.36. Following the sale, the insider now owns 2,000 shares in the company, valued at $259,920. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.22% of the company’s stock.

A number of hedge funds have recently made changes to their positions in the company. Parkside Financial Bank & Trust raised its position in shares of Zimmer Biomet Holdings by 0.5% in the third quarter. Parkside Financial Bank & Trust now owns 964 shares of the company’s stock worth $125,000 after buying an additional 5 shares during the period. IFP Advisors Inc raised its position in shares of Zimmer Biomet Holdings by 0.5% in the second quarter. IFP Advisors Inc now owns 1,507 shares of the company’s stock worth $181,000 after buying an additional 8 shares during the period. Cypress Wealth Advisors LLC raised its position in shares of Zimmer Biomet Holdings by 0.4% in the second quarter. Cypress Wealth Advisors LLC now owns 3,081 shares of the company’s stock worth $371,000 after buying an additional 11 shares during the period. Advisory Services Network LLC raised its position in shares of Zimmer Biomet Holdings by 0.6% in the second quarter. Advisory Services Network LLC now owns 2,496 shares of the company’s stock worth $301,000 after buying an additional 15 shares during the period. Finally, Capital One National Association raised its position in shares of Zimmer Biomet Holdings by 0.3% in the third quarter. Capital One National Association now owns 5,670 shares of the company’s stock worth $738,000 after buying an additional 15 shares during the period. Hedge funds and other institutional investors own 88.87% of the company’s stock.

Related posts

Leave a Comment